Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

CT scan can spare some head and neck cancer patients surgery

20.10.2005


Some patients with head and neck cancer can be safely spared the risk and expense of surgery by undergoing a CT scan to predict whether the disease is in check after radiation therapy, according to study findings University of Florida doctors released today (Oct. 18) at the annual meeting of the American Society for Therapeutic Radiology and Oncology.



Researchers with the UF Shands Cancer Center have identified criteria doctors can use to evaluate CT scans four weeks after patients undergo initial treatment. If these criteria are met, there is a 94 percent likelihood a patient’s lymph nodes are cancer free, said Stanley L. Liauw, M.D., a resident in radiation oncology. Using a CT scan was found to be much more accurate than relying on a physical exam to assess response to treatment.

Radiation therapy is commonly used to treat the more than 40,000 U.S. patients a year who develop advanced head and neck cancer. After radiation therapy, doctors often operate to remove affected lymph nodes. But UF physicians say in some cases surgery is unnecessary, and can increase recovery time, lead to infection and possibly compromise a patient’s quality of life.


The current study builds on previous research involving 95 head and neck cancer patients. In two-thirds of the patients who underwent surgery after radiotherapy, the removed lymph nodes turned out to be cancer free, noted UF radiologist Anthony Mancuso, M.D. Mancuso collaborated with UF radiation oncologists Robert Amdur, M.D., Christopher Morris, M.S., and William Mendenhall, M.D.

By comparing nodes visualized on a CT scan with the same nodes after they were removed, the researchers developed criteria doctors could use to examine nodes using a non-invasive CT scan to identify whether the disease was knocked out. Nodes deemed to be clear of cancer were 1.5 centimeters or smaller and had borders that were sharply defined on the CT scan, rather than fuzzy.

In the current study, UF researchers examined the medical records of 549 patients who were treated with radiotherapy at UF for advanced head and neck cancer between 1990 and 2002; 341 patients later underwent surgery to remove lymph nodes. UF doctors, basing their treatment on the results of the previous research, did not remove lymph nodes in patients who met the CT scan criteria. Results confirmed that a CT scan could be used to reliably predict whether the lymph nodes would be negative for cancer.

A simpler method of CT interpretation (using lymph node size and the presence of an abnormal appearance within the lymph node) predicted, with a 94 percent accuracy, when a patient was cancer free. In 33 patients who were spared neck dissection on the basis of their post-treatment CT scan, only one suffered a recurrence of the disease in the lymph nodes. That patient was then scheduled for surgery, and the involved nodes were successfully removed. The patient recovered.

A newer imaging technology, the PET scan, cannot give an accurate reading of the nodes until two to three months after radiation therapy, making it impossible to surgically intervene in a timely manner, said Mancuso, a co-investigator.

"There is no other alternative method that is effective within the six-week decision-making window," Mancuso said.

Suresh Mukherji, M.D., chief of neuroradiology at the University of Michigan, said the data was promising and could lead to improvements in patient treatment.

"So far this is a single institute study. We need to have multiple institutes adopt this and see if results are similar over the long term," Mukherji said.

Liauw said, "I think it would be great if doctors could look at this data and feel comfortable with just doing a CT scan after radiation in order to know if a neck dissection is necessary. If this data is understood and accepted, we could limit the risk of side effects for several patients. Now it is important to focus more and more on reducing complications and improving quality of life as our treatments are getting better."

Denise Trunk | EurekAlert!
Further information:
http://www.ufl.edu

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>